Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Filed Mar 15, 2022 · 10-Q · 43 days after period end · 0001493152-22-006865
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $416.00K | $916.00K | $349.00K | $394.00K |
| Net Income | -$702.00K | -$595.00K | -$666.00K | -$1.30M |
| EPS Diluted | -$0.01 | -$0.01 | -$0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
ended Jan 31, 2022 · filed Mar 15, 2022 · 43 d after period end
